How much funding has Oxford Nanopore Technologies raised?

Oxford Nanopore Technologies has raised $1.6B in total funding, most recently a Venture Round.

Who are Oxford Nanopore Technologies's investors?

Oxford Nanopore Technologies's investors include IP Group, Illumina Ventures, bioMérieux, Temasek, Wellington Management, M&G Investments.

When was Oxford Nanopore Technologies founded?

Oxford Nanopore Technologies was founded in 2005.

Where is Oxford Nanopore Technologies headquartered?

Oxford Nanopore Technologies is headquartered in London, United Kingdom.

What industry is Oxford Nanopore Technologies in?

Oxford Nanopore Technologies operates in Nanopore Sequencing, Biotech, Healthcare.

How many employees does Oxford Nanopore Technologies have?

Oxford Nanopore Technologies has 1001-5000 employees.

Oxford Nanopore Technologies

To enable the analysis of anything, by anyone, anywhere.

London, United Kingdom · Founded 2005 · $1.6B raised

Nanopore Sequencing

Biotech

Healthcare

Headquarters: London
Employees: 1001–5000
Founded: 2005
Business Model: B2B

Website: nanoporetech.com
Total Funding: $1.6B
Last Round: $140.0M Venture RoundJan 2024
Rounds: 23

About

Oxford Nanopore Technologies, founded in 2005 as a University of Oxford spin-out, develops a novel generation of DNA and RNA sequencing technology. Its devices — from pocket-sized MinION to high-throughput PromethION — enable real-time, long-read sequencing in any environment. The company, listed on the London Stock Exchange (ONT), employs over 1,300 staff and sells to more than 120 countries across research, clinical, and applied markets.

Summary

Oxford Nanopore Technologies is a Nanopore Sequencing company based in London, United Kingdom, founded in 2005. It has raised $1.6B in total across 23 rounds, most recently a $140.0M Venture Round round in Jan 2024. Investors include IP Group, Illumina Ventures and bioMérieux.

LinkedIn X (Twitter)GitHub